Key result
Blue light exacerbates murine type 1 diabetes via NETosis, preventable by pantethine or tranexamic acid.
Why the study?
While several factors that worsen type 1 diabetes are recognized, the effects of blue light irradiation remain obscure.
Does blue light irradiation aggravate STZ-induced type 1 diabetes in mice, and can pantethine or tranexamic acid prevent this effect?
Does blue light irradiation aggravate STZ-induced type 1 diabetes in mice, and can pantethine or tranexamic acid prevent this effect?
Blue light irradiation aggravates STZ-induced type 1 diabetes in mice via NETosis and Agptl2 pathways, an effect that can be mitigated by pantethine or tranexamic acid.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating in diabetic mice; does not support clinical changes in light exposure or NETosis-targeted therapy.
Diabetes mellitus includes type 1 and type 2 diabetes. Type 1 diabetes is an autoimmune disease affecting young people. Although several factors that worsen type 1 diabetes are known, information on the effects of blue light remains obscure. In this study, we investigated the effects of blue light irradiation on diabetes using mice with streptozotocin (STZ)-induced type 1 diabetes. Furthermore, we investigated the potential of selected compounds in rescuing the blue light-induced aggravation of diabetes. Blue light irradiation exacerbated type 1 diabetes. It activated insulin-like growth factor-1 and reactive oxygen species/caspase 3/apoptosis/endothelial-monocyte activating polypeptide II/neutrophil/neutrophil extracellular trap-associated cell death (NETosis) system signaling and increased the expression of angiopoietin-like protein 2 (Agptl2). These results indicate that blue light worsens type 1 diabetes by increasing NETosis production and the expression of Agptl2. Administration of pantethine or tranexamic acid prevented the blue light-induced worsening of type 1 diabetes by suppressing neutrophil production and Agptl2 expression. Our results provide insights into the effects of blue light on type 1 diabetes and highlight the potential of compounds that can be used in ameliorating such effects.
No takes yet. Share an insight, caveat, or question.
Hiramoto et al. (2024) studied STZ-induced Type 1 Diabetes (n=35). Blue light irradiation and Tranexamic acid or Pantethine vs. STZ alone or STZ + blue light was evaluated on Aggravation of diabetes (blood glucose, water intake, urine production, pancreatic damage) (p=<0.05). Blue light irradiation exacerbated STZ-induced type 1 diabetes in mice by increasing NETosis and Agptl2 expression, an effect that was prevented by administration of pantethine or tranexamic acid.
Synapse has enriched 10 related papers. Consider them for comparative context: